NRSN icon

NeuroSense Therapeutics

11 hedge funds and large institutions have $181K invested in NeuroSense Therapeutics in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
-2
Holders Change %
-15.38%
% of All Funds
0.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
3
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Morgan Stanley
1
Morgan Stanley
New York
$47K -$48.4K -52,080 -51%
MIH
2
Meitav Investment House
Israel
$37.2K
XT
3
XTX Topco
Cayman Islands
$31K -$7.54K -8,191 -20%
Commonwealth Equity Services
4
Commonwealth Equity Services
Massachusetts
$16K +$928 +1,000 +6%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$14.6K
TSS
6
Two Sigma Securities
New York
$13.7K -$290 -312 -2%
WAM
7
Warberg Asset Management
Illinois
$9.95K
HC
8
Hurley Capital
New York
$8.1K +$8.1K +8,710 New
UBS Group
9
UBS Group
Switzerland
$2.12K +$2.12K +2,275 New
Carson Wealth (CWM LLC)
10
Carson Wealth (CWM LLC)
Nebraska
$1K
SS
11
SBI Securities
Japan
$163
Citadel Advisors
12
Citadel Advisors
Florida
-$305K -253,997 Closed
Jane Street
13
Jane Street
New York
-$77.6K -64,636 Closed
HF
14
HRT Financial
New York
-$77K -64,390 Closed
SWP
15
Stratos Wealth Partners
Ohio
-$24K -20,000 Closed